MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hemifacial spasm(HFS)"

  • 2017 International Congress

    Unusual facial synkinesia after Bell’s palsy: interactive Marin-Amat syndrome proven by surface electromyogram, successfully treated with low dose botulinum toxin A.

    H. Mori (Kurashiki, Japan)

    Objective: To clarify unusal facial synkinesia by using surface electromyogram and botulinum toxin A. Background: Marin-Amat syndrome is a facial synkinesis manifesting as involuntary eyelid…
  • 2017 International Congress

    The clinical and neuroimaging analysis in hemifacial spasm with associated cranial neuropathy: retrospective case series study

    Y.-Y. Chang, Y.-F. Chen, Y.-F. Chen, M.-Y. Lan, J.-S. Liu (Kaohsiung, Taiwan)

    Objective: To evaluate the clinical characteristics and neuroimaging findings observed in the association between hemifacial spasms (HFS) and other cranial neuropathy in a cohort of…
  • 2017 International Congress

    Differences between Hemifacial spasm with or without neurovascular conflict. Therapeutic implications with botulinum toxin type A.

    J.S. Bestoso, L. Ciancaglini, C. Stefani, C. Azcona, M.L. Contartese, A. Pappolla, J.I. Rojas, D. Bauso (Buenos Aires, Argentina)

    Objective: To evaluate the presence of possible clinical differences between patients with HS with and without neurovascular conflict (NVC +, NVC-) and their therapeutic response…
  • 2017 International Congress

    Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

    O. Dogu, H. Kalegasi (Mersin, Turkey)

    Objective: To assess the frequency of Babinski-2 sign among patients with hemifacial spasm (HFS). Background: The Babinski-2 sign (“the other” Babinski sign, “brow-lift sign”), is…
  • 2017 International Congress

    What does the severity of hemifacial spasm mean to us?

    J. Youn, J.W. Cho (Seoul, Republic of Korea)

    Objective: We investigated the clinical meaning of the severity of hemifacial spasm (HFS) in the patients who performed microvascular decompression (MVD). Background: Even though the most…
  • 2016 International Congress

    Prevalence of hemifacial spasm in Northern Cyprus

    S. Usar Incirli, F. Selcuk, C.M. Akbostanci (Nicosia, Cyprus)

    Objective: To estimate the prevalence and analyze the clinical profile of hemifacial spasm in Northern Cyprus. Background: Hemifacial spasm (HFS) is characterized by involuntary, clonic…
  • 2016 International Congress

    Hemifacial spasm – Therapeutic assessment of botulinum toxin

    H.A.G. Teive, J.P. Matisti, A.D. Kleinfelder, N.B. Galli (Curitiba, Brazil)

    Objective: To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm (HFS) in a large group of patients…
  • 2016 International Congress

    Hemifacial spasm: Objective computation of vertebrobasilar vascular sinuosity

    L. Chan, E.C. Edmond, S.X.L. Sim, H. Li, E. Tan (Singapore, Singapore)

    Objective: To objectively compute the degree of vascular sinuosity in the vertebrobasilar arteries in hemifacial spasm (HFS) and control subjects using a case-control MRI/A approach.…
  • 2016 International Congress

    Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm

    C.V. Chirumamilla, G. Deuschl, K.E. Zeuner, M. Muthuraman, S. Groppa (Mainz, Germany)

    Objective: The two primary objectives of this study were to investigate the structural grey matter changes and connectivity differences between patients with BEB and HFS…
  • 2016 International Congress

    Therapeutic effect of onabotulinumtoxinA (BoNT/A) in hemifacial spasm and trigeminal neuralgia post Ramsay Hunt Syndrome type II

    R. López-Castellanos, R. López-Contreras (San Salvador, El Salvador)

    Objective: To evaluate the therapeutic and preventive effect of OnabotulinumtoxinA (BoNT/A) in the treatment of hemifacial spasm, bruxism, and trigeminal neuralgia post Ramsay Hunt Syndrome.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Unusual prolonged survival in multiple system atrophy: A case report
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley